87 related articles for article (PubMed ID: 3602698)
1. [Disposition of theophylline in healthy non-smoker volunteers after a single oral dose of aminophylline].
Prat G; Gazitúa R; Arriagada D; Montero J; Serrat H; Ruiz M; Leiva P
Rev Med Chil; 1986 Dec; 114(12):1164-7. PubMed ID: 3602698
[No Abstract] [Full Text] [Related]
2. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
Schuppan D; Molz KH; Staib AH; Rietbrock N
Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
[TBL] [Abstract][Full Text] [Related]
3. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
Schulz HU; Steinijans VW; Gabel H
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
[TBL] [Abstract][Full Text] [Related]
4. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
5. [Biopharmaceutical evaluation of aminophylline suppositories. II. Biological availability of aminophylline (theophylline) from suppositories with normal and prolonged time of total deformation].
Masiakowski J; Cieszyński T; Dyderski S; Perz A
Acta Pol Pharm; 1984; 41(1):105-10. PubMed ID: 6496133
[No Abstract] [Full Text] [Related]
6. [Bioavailability of a delayed-action aminophylline preparation].
Regazzi MB; Guarnone E; Bartoli A; Ciardelli L; Piacentini P
Minerva Med; 1985 Mar; 76(13):641-5. PubMed ID: 3991030
[TBL] [Abstract][Full Text] [Related]
7. [Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation].
Masiakowski J; Cieszyński T; Dyderski S; Perz A
Acta Pol Pharm; 1984; 41(1):99-104. PubMed ID: 6496143
[No Abstract] [Full Text] [Related]
8. Plasma concentrations of theophylline and quinine in healthy volunteers following oral administration of a fixed drug combination.
Dieterich HA; Messer W; Jaehnchen E
Arzneimittelforschung; 1984; 34(4):520-2. PubMed ID: 6540112
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of theophylline and aminophylline in man.
Aslaksen A; Bakke OM; Vigander T
Br J Clin Pharmacol; 1981 Mar; 11(3):269-73. PubMed ID: 7213528
[TBL] [Abstract][Full Text] [Related]
10. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
11. [Pharmaceutical and biological availability of theophylline from suppositories with or without aminophylline and with the addition of aerosil].
Masiakowski J; Cieszyński T; Dyderski S; Perz A
Acta Pol Pharm; 1984; 41(2):253-7. PubMed ID: 6097098
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics of theophylline in asthmatic children after multiple oral doses of aminophylline tablets.
Hasegawa T; Ogura Y; Takeshi K; Mizukami Y
Arerugi; 1984 Jun; 33(6):303-7. PubMed ID: 6497661
[No Abstract] [Full Text] [Related]
13. Comparative serum theophylline levels following the oral administration of elixophyllin and somophyllino-O, a new preparation of aminophylline.
Sherter C; Denefrio J
Curr Ther Res Clin Exp; 1974 Mar; 16(3):239-42. PubMed ID: 4206731
[No Abstract] [Full Text] [Related]
14. Pirenzepin does not alter the pharmacokinetics of theophylline.
Sertl K; Rameis H; Meryn S
Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):15-7. PubMed ID: 3557724
[TBL] [Abstract][Full Text] [Related]
15. The use of theophylline clearance to design an oral aminophylline regimen.
Simmons SM; Camp RB; Mungall DR; Bailey WC
Ala J Med Sci; 1982 Apr; 19(2):142-6. PubMed ID: 7102998
[No Abstract] [Full Text] [Related]
16. Bioavailability of theophylline following a rectally administered concentrated aminophylline solution.
Mason WD; Lanman RC; Amick EN; Arnold J; March L
J Allergy Clin Immunol; 1980 Aug; 66(2):119-22. PubMed ID: 7400475
[TBL] [Abstract][Full Text] [Related]
17. Theophylline: constant-rate infusion predictions.
Mesquita CA; Sahebjami H; Imhoff T; Thomas JP; Myre SA
Ther Drug Monit; 1984; 6(2):157-63. PubMed ID: 6740734
[TBL] [Abstract][Full Text] [Related]
18. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
Wiessmann KJ
Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic research on theophylline].
Tsoĭ AN; Gneushev ET; Bogovskiĭ BP; Kaz'mina EM; Abrosimov AG
Farmakol Toksikol; 1987; 50(1):89-91. PubMed ID: 3556561
[TBL] [Abstract][Full Text] [Related]
20. Theophylline pharmacokinetics in paraplegic subjects.
Segal JL; Smith CM; Gordon SK; Eltorai IM
Clin Pharm; 1985; 4(4):448-51. PubMed ID: 4042560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
